Ocean Biomedical, INC. (OCEA) — 8-K Filings

All 8-K filings from Ocean Biomedical, INC.. Browse 29 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (29)

Ocean Biomedical Faces Delisting Concerns, Officer Changes — Aug 5, 2025 Risk: high
Ocean Biomedical, Inc. filed an 8-K on August 5, 2025, reporting events as of July 31, 2025. The filing indicates a potential delisting or failure to meet listi
Ocean Biomedical Faces Delisting Concerns — Jul 23, 2025 Risk: high
Ocean Biomedical, Inc. filed an 8-K on July 23, 2025, reporting a notice of delisting or failure to satisfy continued listing rules as of July 17, 2025. The com
Ocean Biomedical Terminates Material Definitive Agreement — Jul 16, 2025 Risk: medium
Ocean Biomedical, Inc. announced on July 10, 2025, the termination of a material definitive agreement. The company, formerly known as Aesther Healthcare Acquisi
Ocean Biomedical Terminates Material Definitive Agreement — Jun 13, 2025 Risk: medium
Ocean Biomedical, Inc. announced on June 12, 2025, the termination of a material definitive agreement. The company, formerly known as Aesther Healthcare Acquisi
Ocean Biomedical Faces Delisting Concerns — Apr 23, 2025 Risk: high
Ocean Biomedical, Inc. filed an 8-K on April 23, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The filing also covers th
Ocean Biomedical Files 8-K on Shareholder Vote Matters — Apr 1, 2025 Risk: low
Ocean Biomedical, Inc. filed an 8-K on April 1, 2025, reporting on matters submitted to a vote of its security holders as of March 28, 2025. The filing details
Ocean Biomedical to Acquire Algaeventures — Mar 26, 2025 Risk: medium
Ocean Biomedical, Inc. announced on March 26, 2025, that it has entered into a definitive agreement to acquire all outstanding shares of Algaeventures, Inc. The
Ocean Biomedical Faces Delisting Concerns — Mar 20, 2025 Risk: high
Ocean Biomedical, Inc. filed an 8-K on March 20, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing in
Ocean Biomedical Announces Board and Officer Changes — Mar 10, 2025 Risk: medium
Ocean Biomedical, Inc. announced on March 4, 2025, changes in its board of directors and officer appointments. Specifically, the company elected new directors a
Ocean Biomedical Files 8-K on Equity Sales & Bylaw Changes — Feb 26, 2025 Risk: medium
Ocean Biomedical, Inc. filed an 8-K on February 26, 2025, reporting unregistered sales of equity securities and amendments to its articles of incorporation or b
Ocean Biomedical Files 8-K for Bylaw Amendments & Fiscal Year Change — Feb 21, 2025 Risk: low
Ocean Biomedical, Inc. filed an 8-K on February 21, 2025, reporting amendments to its Articles of Incorporation or Bylaws, and a change in its fiscal year. The
Ocean Biomedical Reports Unregistered Equity Sales — Feb 12, 2025 Risk: medium
Ocean Biomedical, Inc. filed an 8-K on February 12, 2025, reporting unregistered sales of equity securities and other events that occurred on February 11, 2025.
Ocean Biomedical Faces Nasdaq Delisting Warning — Jan 15, 2025 Risk: high
Ocean Biomedical, Inc. received a notice on January 7, 2025, regarding its failure to meet the continued listing requirements of the Nasdaq Capital Market. The
Ocean Biomedical Changes Auditors — Dec 17, 2024 Risk: low
Ocean Biomedical, Inc. announced on December 17, 2024, a change in its certifying accountant. The company has dismissed its previous independent registered publ
Ocean Biomedical Faces Delisting Concerns — Dec 11, 2024 Risk: high
Ocean Biomedical, Inc. filed an 8-K on December 11, 2024, to report a notice of delisting or failure to satisfy continued listing rules. The company's common st
Ocean Biomedical Faces Delisting Concerns — Dec 9, 2024 Risk: high
Ocean Biomedical, Inc. filed an 8-K on December 9, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing
Ocean Biomedical Changes Auditors to Marcum LLP — Dec 6, 2024 Risk: medium
Ocean Biomedical, Inc. filed an 8-K on December 6, 2024, reporting a change in its certifying accountant. The company has appointed Marcum LLP as its new indepe
Ocean Biomedical Faces Delisting Concerns — Nov 22, 2024 Risk: high
Ocean Biomedical, Inc. filed an 8-K on November 22, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule. The filing indicates p
Ocean Biomedical Appoints New CMO, Elects Director — Oct 29, 2024 Risk: medium
Ocean Biomedical, Inc. announced on October 23, 2024, the appointment of Dr. Jonathan Roth as Chief Medical Officer and the election of Dr. David Lee to its Boa
Ocean Biomedical Faces Delisting Notice — Oct 22, 2024 Risk: high
Ocean Biomedical, Inc. filed an 8-K on October 22, 2024, reporting a notice of delisting or failure to satisfy continued listing rules as of October 16, 2024. T
Ocean Biomedical Enters Material Definitive Agreement — Oct 17, 2024 Risk: medium
Ocean Biomedical, Inc. entered into a Material Definitive Agreement on October 11, 2024. The filing also includes financial statements and exhibits related to t
Ocean Biomedical Faces Delisting Concerns — Aug 23, 2024 Risk: high
Ocean Biomedical, Inc. filed an 8-K on August 19, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company is also prov
Ocean Biomedical Files 8-K: Material Agreement & Equity Sales — Jul 23, 2024 Risk: medium
Ocean Biomedical, Inc. entered into a material definitive agreement on July 22, 2024, related to the creation of a direct financial obligation. The company also
Ocean Biomedical Faces Delisting Concerns — May 30, 2024 Risk: high
Ocean Biomedical, Inc. filed an 8-K on May 22, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule. The company, previously kno
Ocean Biomedical Faces Delisting Concerns — Apr 24, 2024 Risk: high
Ocean Biomedical, Inc. filed an 8-K on April 24, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing in
Ocean Biomedical Elects New Director — Mar 8, 2024 Risk: low
Ocean Biomedical, Inc. announced on March 4, 2024, a change in its board of directors. Specifically, the company elected Dr. Jonathan Roth as a new director. Th
Ocean Biomedical Appoints New Director, Reports Officer Compensation — Mar 4, 2024 Risk: medium
Ocean Biomedical, Inc. announced on January 30, 2024, a change in its board of directors. Specifically, the company reported the departure of Director Dr. Jonat
Ocean Biomedical (OCEA) to be Delisted from Nasdaq Jan 29 — Jan 19, 2024
Ocean Biomedical, Inc. (OCEA) announced on January 17, 2024, that it received a delisting notice from The Nasdaq Stock Market LLC because its common stock and w
Ocean Biomedical Receives Nasdaq Delisting Notice for Non-Compliance — Jan 17, 2024
Ocean Biomedical, Inc. (OCEA) announced on January 11, 2024, that it received a delisting notice from The Nasdaq Stock Market LLC. This notice indicates that th

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX